JP2025513882A5 - - Google Patents
Info
- Publication number
- JP2025513882A5 JP2025513882A5 JP2024560672A JP2024560672A JP2025513882A5 JP 2025513882 A5 JP2025513882 A5 JP 2025513882A5 JP 2024560672 A JP2024560672 A JP 2024560672A JP 2024560672 A JP2024560672 A JP 2024560672A JP 2025513882 A5 JP2025513882 A5 JP 2025513882A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heterocycloalkyl
- cycloalkyl
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331073P | 2022-04-14 | 2022-04-14 | |
| US63/331,073 | 2022-04-14 | ||
| US202363486559P | 2023-02-23 | 2023-02-23 | |
| US63/486,559 | 2023-02-23 | ||
| PCT/US2023/018508 WO2023200964A1 (en) | 2022-04-14 | 2023-04-13 | Protein tyrosine phosphatase inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513882A JP2025513882A (ja) | 2025-04-30 |
| JP2025513882A5 true JP2025513882A5 (enExample) | 2026-04-20 |
Family
ID=88330255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560672A Pending JP2025513882A (ja) | 2022-04-14 | 2023-04-13 | タンパク質チロシンホスファターゼ阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250257059A1 (enExample) |
| EP (1) | EP4508050A4 (enExample) |
| JP (1) | JP2025513882A (enExample) |
| CN (1) | CN119365452A (enExample) |
| TW (1) | TW202404964A (enExample) |
| WO (1) | WO2023200964A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250011138A (ko) * | 2022-05-13 | 2025-01-21 | 네스 테라퓨틱스 인코포레이티드 | Ptpn2 저해제 |
| JP2025539027A (ja) * | 2022-11-09 | 2025-12-03 | ブリストル－マイヤーズ スクイブ カンパニー | タンパク質チロシンホスファターゼの阻害剤、組成物、および使用方法 |
| WO2024243441A1 (en) * | 2023-05-24 | 2024-11-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2025030008A1 (en) * | 2023-08-02 | 2025-02-06 | Nerio Therapeutics, Inc. | Protein tyrosine phosphatase inhibitor combinations |
| CN119707953B (zh) * | 2024-04-19 | 2026-07-31 | 中国药科大学 | 噻二唑烷酮衍生物及其制备方法和应用 |
| WO2026037253A1 (zh) * | 2024-08-10 | 2026-02-19 | 杭州英创医药科技有限公司 | 作为ptpn抑制剂的化合物 |
| TW202615014A (zh) * | 2024-08-22 | 2026-04-16 | 大陸商武漢人福創新藥物研發中心有限公司 | 作為蛋白質酪氨酸磷酸酶抑制劑的含雙鍵取代的化合物及其應用 |
| WO2026112354A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026112353A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2026112355A1 (en) * | 2024-11-22 | 2026-05-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2008127253A (ru) * | 2005-12-08 | 2010-01-20 | Новартис АГ (CH) | 1,1,3-триоксо-1,2,5-тиадиазолидины и их применение в качестве ингибиторов птфаз |
| JP2009532379A (ja) * | 2006-03-31 | 2009-09-10 | ノバルティス アクチエンゲゼルシャフト | ＰＴＰａｓｅのチアジアゾリジノン阻害剤 |
| KR102983496B1 (ko) * | 2019-03-14 | 2026-06-29 | 칼리코 라이프 사이언시스 엘엘씨 | 단백질 티로신 포스파타제 억제제 및 이의 사용 방법 |
| EP4351558A4 (en) * | 2021-06-10 | 2025-05-07 | Ness Therapeutics, Inc. | Compounds containing 5-(2-fluoro-6-hydroxyphenyl)-1,2,5-thiazolidin-3-one 1,1-dioxide as inhibitors of protein kinase phosphatase enzymes |
-
2023
- 2023-04-13 WO PCT/US2023/018508 patent/WO2023200964A1/en not_active Ceased
- 2023-04-13 EP EP23788952.2A patent/EP4508050A4/en active Pending
- 2023-04-13 JP JP2024560672A patent/JP2025513882A/ja active Pending
- 2023-04-13 CN CN202380044895.6A patent/CN119365452A/zh active Pending
- 2023-04-13 TW TW112113773A patent/TW202404964A/zh unknown
- 2023-04-13 US US18/855,786 patent/US20250257059A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520481A5 (enExample) | ||
| JP2020169171A5 (enExample) | ||
| RU2011134634A (ru) | Индуцирующие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний | |
| JP2021527638A5 (enExample) | ||
| JP2025024130A5 (enExample) | ||
| JP2020530487A5 (enExample) | ||
| JP2023533203A5 (enExample) | ||
| JP2017506250A5 (enExample) | ||
| RU2008130094A (ru) | Модуляторы мускариновых рецепторов | |
| RU2012143212A (ru) | Способ лечения артрита | |
| JP2021523200A5 (enExample) | ||
| JP2012526728A5 (enExample) | ||
| JP2021522280A5 (enExample) | ||
| JP2021527051A5 (enExample) | ||
| JP2024541910A5 (enExample) | ||
| JP2025507292A5 (enExample) | ||
| JP2015535831A5 (enExample) | ||
| JP2025503953A5 (enExample) | ||
| JP2021046404A5 (enExample) | ||
| RU97102362A (ru) | Нейрозащитные производные 3-(пиперидинил-1)-хроман-4,7-диола и 1-(4- гидроксифенил)-2-(пиперидинил-1)-алканола | |
| JP2011529468A5 (enExample) | ||
| JP2014514290A5 (enExample) | ||
| JP2023541203A5 (enExample) | ||
| JP2025502943A5 (enExample) | ||
| JP2025507915A5 (enExample) |